Cadonilimab is effective and safe in recurrent cervical cancer

Saved in:
Bibliographic Details
Published in:Nature reviews. Clinical oncology 2025-01, Vol.22 (1), p.2-2
Main Author: Romero, Diana
Format: Article
Language:English
Subjects:
Cervical cancer
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c212t-afd222b0dff9fdee43943a178f80576c8bf05641be24caee1ca905f3e2a03aa33
container_end_page 2
container_issue 1
container_start_page 2
container_title Nature reviews. Clinical oncology
container_volume 22
creator Romero, Diana
description
doi_str_mv 10.1038/s41571-024-00962-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3121059274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3121059274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c212t-afd222b0dff9fdee43943a178f80576c8bf05641be24caee1ca905f3e2a03aa33</originalsourceid><addsrcrecordid>eNpdkEtLw0AUhQdRbK3-ARcy4MZNdJ6ZZCNIqQ8ouNH1cDO5AylpUmeSgv_eqa1duLpn8d3D4SPkmrN7zmTxEBXXhmdMqIyxMheZPCFTbnSZKVOI02M2akIuYlwxlufKyHMykaXSujBySh7nUPdd0zZrqGgTKXqPbmi2SKGraQSPtOloQDeGgN1AHYZt46ClDrqUL8mZhzbi1eHOyOfz4mP-mi3fX97mT8vMCS6GDHwthKhY7X3pa0SVBkjgpvAF0yZ3ReWZzhWvUCgHiNxBybSXKIBJACln5G7fuwn914hxsOsmOmxb6LAfo5VccKZLYVRCb_-hq34MXVqXKJUMaJmbRIk95UIfY0BvNyE5CN-WM7uza_d2bbJrf-3a3YqbQ_VYrbE-vvzplD8MoHRd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146645367</pqid></control><display><type>article</type><title>Cadonilimab is effective and safe in recurrent cervical cancer</title><source>Alma/SFX Local Collection</source><creator>Romero, Diana</creator><creatorcontrib>Romero, Diana</creatorcontrib><identifier>ISSN: 1759-4774</identifier><identifier>ISSN: 1759-4782</identifier><identifier>EISSN: 1759-4782</identifier><identifier>DOI: 10.1038/s41571-024-00962-3</identifier><identifier>PMID: 39455873</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Cervical cancer</subject><ispartof>Nature reviews. Clinical oncology, 2025-01, Vol.22 (1), p.2-2</ispartof><rights>Copyright Nature Publishing Group Jan 2025</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c212t-afd222b0dff9fdee43943a178f80576c8bf05641be24caee1ca905f3e2a03aa33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39455873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Romero, Diana</creatorcontrib><title>Cadonilimab is effective and safe in recurrent cervical cancer</title><title>Nature reviews. Clinical oncology</title><addtitle>Nat Rev Clin Oncol</addtitle><subject>Cervical cancer</subject><issn>1759-4774</issn><issn>1759-4782</issn><issn>1759-4782</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLw0AUhQdRbK3-ARcy4MZNdJ6ZZCNIqQ8ouNH1cDO5AylpUmeSgv_eqa1duLpn8d3D4SPkmrN7zmTxEBXXhmdMqIyxMheZPCFTbnSZKVOI02M2akIuYlwxlufKyHMykaXSujBySh7nUPdd0zZrqGgTKXqPbmi2SKGraQSPtOloQDeGgN1AHYZt46ClDrqUL8mZhzbi1eHOyOfz4mP-mi3fX97mT8vMCS6GDHwthKhY7X3pa0SVBkjgpvAF0yZ3ReWZzhWvUCgHiNxBybSXKIBJACln5G7fuwn914hxsOsmOmxb6LAfo5VccKZLYVRCb_-hq34MXVqXKJUMaJmbRIk95UIfY0BvNyE5CN-WM7uza_d2bbJrf-3a3YqbQ_VYrbE-vvzplD8MoHRd</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>Romero, Diana</creator><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20250101</creationdate><title>Cadonilimab is effective and safe in recurrent cervical cancer</title><author>Romero, Diana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c212t-afd222b0dff9fdee43943a178f80576c8bf05641be24caee1ca905f3e2a03aa33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Cervical cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Romero, Diana</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Romero, Diana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cadonilimab is effective and safe in recurrent cervical cancer</atitle><jtitle>Nature reviews. Clinical oncology</jtitle><addtitle>Nat Rev Clin Oncol</addtitle><date>2025-01-01</date><risdate>2025</risdate><volume>22</volume><issue>1</issue><spage>2</spage><epage>2</epage><pages>2-2</pages><issn>1759-4774</issn><issn>1759-4782</issn><eissn>1759-4782</eissn><cop>England</cop><pub>Nature Publishing Group</pub><pmid>39455873</pmid><doi>10.1038/s41571-024-00962-3</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1759-4774
ispartof Nature reviews. Clinical oncology, 2025-01, Vol.22 (1), p.2-2
issn 1759-4774
1759-4782
1759-4782
language eng
recordid cdi_proquest_miscellaneous_3121059274
source Alma/SFX Local Collection
subjects Cervical cancer
title Cadonilimab is effective and safe in recurrent cervical cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cadonilimab%20is%20effective%20and%20safe%20in%20recurrent%20cervical%20cancer&rft.jtitle=Nature%20reviews.%20Clinical%20oncology&rft.au=Romero,%20Diana&rft.date=2025-01-01&rft.volume=22&rft.issue=1&rft.spage=2&rft.epage=2&rft.pages=2-2&rft.issn=1759-4774&rft.eissn=1759-4782&rft_id=info:doi/10.1038/s41571-024-00962-3&rft_dat=%3Cproquest_cross%3E3121059274%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c212t-afd222b0dff9fdee43943a178f80576c8bf05641be24caee1ca905f3e2a03aa33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3146645367&rft_id=info:pmid/39455873&rfr_iscdi=true